Pretreatment prostate-specific antigen doubling times: clinical utility of this predictor of prostate cancer behavior-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pretreatment prostate-specific antigen doubling times: clinical utility of this predictor of prostate cancer behavior

Published:1996-02 Issue:3 Volume:34 Page:549-553
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Hanks Gerald E.,Hanlon Alexandra L.,Lee W.Robert,Slivjak Anne,Schultheiss Timothy E.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference15 articles.

1. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease;Carter;JAMA,1992

2. Proliferative cell nuclear antigen in postradiotherapy prostate biopsies;Crook;Int. J. Radiat. Oncol. Biol. Phys.,1994

3. Linear regressive analysis using PSA doubling time predicts tumor biology and clinical out-come in prostate cancer;D'Amico;Cancer,1993

4. Prostatic-specific antigen doubling times in patients with prostate cancer: A potentially useful reflection of tumor doubling time;Hanks;Int. J. Radiat. Oncol. Biol. Phys.,1993

5. Clinical and biochemical evidence of control of prostate cancer at five years after external beam radiation;Hanks;J. Urol.,1995

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical significance of the prostate-specific antigen doubling time prior to and following radical prostatectomy to predict the outcome of prostate cancer;Molecular and Clinical Oncology;2016-12-22

2. Prostate Cancer;Clinical Radiation Oncology;2016

3. Preoperative CA 19-9 kinetics as a prognostic variable in radiographically resectable pancreatic adenocarcinoma;Journal of Surgical Oncology;2014-10-20

4. Genome Abnormalities Precede Prostate Cancer and Predict Clinical Relapse;The American Journal of Pathology;2012-06

5. Risk Stratification after Biochemical Failure following Curative Treatment of Locally Advanced Prostate Cancer: Data from the TROG 96.01 Trial;Prostate Cancer;2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3